{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:13:22Z","timestamp":1789913602403,"version":"4.0.1"},"reference-count":53,"publisher":"Informa UK Limited","issue":"1","funder":[{"name":"Key Research and Development program of Hunan Provincial Science and Technology Department"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharmacogenomics"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.2217\/pgs-2016-0103","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T16:30:24Z","timestamp":1482165024000},"page":"35-56","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":34,"title":["Trough Concentration and\n            <i>ABCG2<\/i>\n            Polymorphism are Better to Predict Imatinib Response in Chronic Myeloid Leukemia: A Meta-Analysis"],"prefix":"10.1080","volume":"18","author":[{"given":"Zhi-Ping","family":"Jiang","sequence":"first","affiliation":[{"name":"Laboratory of Clinical Pharmacology, Department of Hematology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan Province410008, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xie-Lan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacology, Department of Hematology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan Province410008, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nephrology, &amp; Rheumatology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita city, Akita010-8543, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Angelini","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Bologna, Bologna40126, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswajit","family":"Dubashi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education &amp; Research (JIPMER), Puducherry605 006, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy &amp; Pharmacology Research Institute, the Second Xiangya Hospital, Central South University, 139 Renmin Middle Road, Changsha, Hunan Province410011, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Xu","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy &amp; Pharmacology Research Institute, the Second Xiangya Hospital, Central South University, 139 Renmin Middle Road, Changsha, Hunan Province410011, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2016,12,19]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.104"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2091"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2008.07.015"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1159\/000336244"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b15-00103"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2250"},{"issue":"8","key":"e_1_3_3_8_1","first-page":"611","article-title":"C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance","volume":"1","author":"Imai Y","unstructured":"Imai Y , NakaneM , KageKet al. C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance . Mol. Cancer Ther.1 ( 8 ), 611 \u2013 616 .","journal-title":"Mol. Cancer Ther."},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.4068\/cmj.2014.50.3.102"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2014.06.009"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-147744"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2014.54"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.4238\/2015.November.24.4"},{"key":"e_1_3_3_14_1","first-page":"37","volume-title":"Methods for Meta-Analysis in Medical Research","author":"Sutton AJ","year":"2000","unstructured":"Sutton AJ , AbramsKR , JonesDRet al. Methods for Meta-Analysis in Medical Research . John Wiley & Sons Ltd , Chichester, UK , 37 \u2013 160 ( 2000 )."},{"issue":"3","key":"e_1_3_3_15_1","first-page":"183","article-title":"Analysis of plasma trough level of imatinib in Chinese CML patients","volume":"33","author":"Zhou L","year":"2012","unstructured":"Zhou L , MengFY , JinJet al. Analysis of plasma trough level of imatinib in Chinese CML patients . Zhonghua Xue Ye Xue Za Zhi.33 ( 3 ), 183 \u2013 186 ( 2012 ) [Chinese] .","journal-title":"Zhonghua Xue Ye Xue Za Zhi."},{"issue":"7","key":"e_1_3_3_16_1","first-page":"450","article-title":"Monitoring of plasma concentration of imatinib mesylate in patients with chronic myeloid leukemia","volume":"32","author":"Chen C","year":"2011","unstructured":"Chen C , WangW , XuCGet al. Monitoring of plasma concentration of imatinib mesylate in patients with chronic myeloid leukemia . Zhonghua Xue Ye Xue Za Zhi.32 ( 7 ), 450 \u2013 453 ( 2011 ).","journal-title":"Zhonghua Xue Ye Xue Za Zhi."},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-011-0838-3"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-036012"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-116475"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.186"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051771"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1159\/000365437"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.085167"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2010.01643.x"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2010.79"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/jhg.2010.98"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2005.02392.x"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds532"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2014.01.009"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0851-5"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-3874-4"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-015-2905-6"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0145"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-1638"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2010.12.004"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2011.11.001"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-296954"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.3087"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-298794"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0279-y"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.066480"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2016.3127"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-010-9456-9"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1179\/1607845413Y.0000000102"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.3892\/or.2012.2153"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1159\/000440936"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e318284ef11"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2062-2"},{"issue":"5","key":"e_1_3_3_49_1","first-page":"445","article-title":"MDR1 (ABCB1) polymorphisms: functional effects and clinical implications","volume":"65","author":"Brambila-Tapia AJ","year":"2013","unstructured":"Brambila-Tapia AJ . MDR1 (ABCB1) polymorphisms: functional effects and clinical implications . Rev. Invest. Clin.65 ( 5 ), 445 \u2013 454 ( 2013 ).","journal-title":"Rev. Invest. Clin."},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2006.05.003"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0950"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0145"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.13.222"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2016.1184649"}],"container-title":["Pharmacogenomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/pgs-2016-0103","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T02:06:38Z","timestamp":1715997998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/pgs-2016-0103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,19]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.2217\/pgs-2016-0103"],"URL":"https:\/\/doi.org\/10.2217\/pgs-2016-0103","relation":{},"ISSN":["1462-2416","1744-8042"],"issn-type":[{"value":"1462-2416","type":"print"},{"value":"1744-8042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-06-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-09-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-12-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}